Wire · regulatory
MHRA announces strategy to streamline regulation in the AI era
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 14 October 2026 · Fusion42 review
The UK MHRA has announced a multi-year strategy through 2030 to streamline regulation with a focus on AI and personalized medicine. The plan includes faster review timelines, expanded use of real-world data, AI-driven regulatory tools, and enhanced international cooperation to accelerate access to safe and effective treatments.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 4 sources have reported it between 6 Oct 2026 and 15 Oct 2026.
◆ ◆ The Wire takeaway
UK healthtech founders face faster approval and clearer AI regulation as MHRA cuts review times and launches new AI tools. International alignment opens doors to UK market entry while raising the bar for AI-driven medical devices.
◆ Coverage
4 sources · first reported 6 Oct 2026 · latest 15 Oct 2026
◆ Related on Wire
◆ Topics